1. Home
  2. CALC vs MOGO Comparison

CALC vs MOGO Comparison

Compare CALC & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • MOGO
  • Stock Information
  • Founded
  • CALC 2011
  • MOGO 2003
  • Country
  • CALC United States
  • MOGO Canada
  • Employees
  • CALC N/A
  • MOGO N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • CALC Health Care
  • MOGO
  • Exchange
  • CALC Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • CALC 22.9M
  • MOGO 25.1M
  • IPO Year
  • CALC N/A
  • MOGO N/A
  • Fundamental
  • Price
  • CALC $1.60
  • MOGO $1.26
  • Analyst Decision
  • CALC Strong Buy
  • MOGO Strong Buy
  • Analyst Count
  • CALC 3
  • MOGO 1
  • Target Price
  • CALC $16.33
  • MOGO $4.00
  • AVG Volume (30 Days)
  • CALC 28.4K
  • MOGO 147.7K
  • Earning Date
  • CALC 08-11-2025
  • MOGO 08-07-2025
  • Dividend Yield
  • CALC N/A
  • MOGO N/A
  • EPS Growth
  • CALC N/A
  • MOGO N/A
  • EPS
  • CALC N/A
  • MOGO N/A
  • Revenue
  • CALC N/A
  • MOGO $28,873,274.00
  • Revenue This Year
  • CALC N/A
  • MOGO $59.16
  • Revenue Next Year
  • CALC N/A
  • MOGO $6.17
  • P/E Ratio
  • CALC N/A
  • MOGO N/A
  • Revenue Growth
  • CALC N/A
  • MOGO 0.62
  • 52 Week Low
  • CALC $1.42
  • MOGO $0.74
  • 52 Week High
  • CALC $5.97
  • MOGO $2.73
  • Technical
  • Relative Strength Index (RSI)
  • CALC 32.78
  • MOGO 49.85
  • Support Level
  • CALC $1.48
  • MOGO $1.15
  • Resistance Level
  • CALC $1.79
  • MOGO $1.31
  • Average True Range (ATR)
  • CALC 0.12
  • MOGO 0.07
  • MACD
  • CALC -0.02
  • MOGO -0.01
  • Stochastic Oscillator
  • CALC 0.00
  • MOGO 45.45

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

Share on Social Networks: